A powerful new way to treat HER2-positive breast cancer validated
In a recent study at Cold Spring Harbor Laboratory (CSHIL), scientists discovered a powerful new way of treating an aggressive […]
Say something
Tags: biology, Breast Cancer, Business Partnership, charged active binding site, Cold Spring Harbor Laboratory, diabetes, Disease, Dr. Tonks, Health/Medical/Pharmaceuticals, illness, lead author, Long Island Jewish Hospital, medicine, metastasis, mice modeling HER2-positive breast cancer, Molecular biologists, Nature Chemical Biology, Navasona Krishnan, Nicholas Tonks, North Shore-Long Island Jewish Hospital, Obesity, OHR PHARMACEUTICAL INC., Oncogenes, oncologists, Oncology, Ph.D., postdoctoral investigator in the Tonks lab, professor, Ribbon symbolism, Trastuzumab, tumor, tumors, Tyrosine kinase receptors
-
-
Flipkart Health+ App Launched
06-04-2022
